This website uses cookies.

By clicking the "Accept" button or continuing to browse our site, you agree to first-party and session-only cookies being stored on your device to enhance site navigation and analyze site performance and traffic. For more information on our use of cookies, please see our Privacy Policy.

  1. Home
  2. Journals
  3. Journal of Economic Perspectives
  4. Fall 2002
  5. Pharmaceuticals and the Developing World

Journal of Economic Perspectives

ISSN 0895-3309 (Print) | ISSN 1944-7965 (Online)

Pharmaceuticals and the Developing World

  • Michael Kremer
Journal of Economic Perspectives
vol. 16, no. 4, Fall 2002
(pp. 67–90)
Download Full Text PDF
(Complimentary)

Abstract

Pharmaceuticals have greatly improved health in developing countries, but many people in developing countries do not obtain even inexpensive pharmaceuticals and little pharmaceutical R&D is oriented toward products needed by developing countries, such as a malaria vaccine. Access to existing products could be improved by facilitating differential pricing, for example by subsidizing donation programs, and reforming health care delivery. R&D incentives could be improved if rich countries or international organization committed to purchase needed products when they are developed and make them available to the poor.

Citation

Kremer, Michael. 2002. "Pharmaceuticals and the Developing World ." Journal of Economic Perspectives, 16 (4): 67–90. DOI: 10.1257/089533002320950984

JEL Classification

  • L65 Chemicals; Rubber; Drugs; Biotechnology
  • O15 Economic Development: Human Resources; Human Development; Income Distribution; Migration
  • I11 Analysis of Health Care Markets
There are no comments for this article.
Login to Comment